Real-Life Treatment Strategies for Systemic Sclerosis According to Experts

被引:0
|
作者
Fernandez-Codina, Andreu [1 ,2 ]
Walker, Kyle M. [3 ]
Pope, Janet E. [4 ]
机构
[1] Univ Western Ontario, Rheumatol, London, ON, Canada
[2] Hosp Univ Vall dHebron, Syst Autoimmune Dis, Barcelona, Spain
[3] Univ Ottawa, Div Rheumatol, Dept Med, Ottawa, ON, Canada
[4] Univ Western Ontario, London, ON, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2673
引用
下载
收藏
页数:3
相关论文
共 50 条
  • [31] Treatment strategies for hidradenitis suppurativa: real-life data from a tertiary Greek hospital
    Aikaterini Tsentemeidou
    Elena Sotiriou
    Efstratios Vakirlis
    Nikolaos Sideris
    Aimilios Lallas
    Demeter Ioannides
    Archives of Dermatological Research, 2022, 314 : 301 - 305
  • [32] Treatment strategies for hidradenitis suppurativa: real-life data from a tertiary Greek hospital
    Tsentemeidou, Aikaterini
    Sotiriou, Eleni
    Vakirlis, Eustratios
    Sideris, Nikolaos
    Lallas, Aimilios
    Ioannides, Dimitrios
    EXPERIMENTAL DERMATOLOGY, 2020, 29 : 48 - 48
  • [33] Treatment strategies for hidradenitis suppurativa: real-life data from a tertiary Greek hospital
    Tsentemeidou, Aikaterini
    Sotiriou, Elena
    Vakirlis, Efstratios
    Sideris, Nikolaos
    Lallas, Aimilios
    Ioannides, Demeter
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2022, 314 (03) : 301 - 305
  • [34] Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years
    Auer, Michael
    Zinganell, Anne
    Hegen, Harald
    Bsteh, Gabriel
    Di Pauli, Franziska
    Berek, Klaus
    Fava, Elena
    Wurth, Sebastian
    Berger, Thomas
    Deisenhammer, Florian
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [35] Treatment of multiple sclerosis with natalizumab: experiences from a real-life cohort over 15 years
    Auer, M.
    Zinganell, A.
    Hegen, H.
    Bsteh, G.
    Di Pauli, F.
    Berek, K.
    Fava, E.
    Wurth, S.
    Berger, T.
    Deisenhammer, F.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 588 - 588
  • [36] Real-life mobility-response criteria in patients with multiple sclerosis starting fampidrine treatment
    Stellmann, J. -P.
    Neuhaus, A.
    Jlussi, M.
    Heesen, C.
    Daumer, M.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 502 - 503
  • [37] Determinants of therapy switch in multiple sclerosis treatment-naive patients: A real-life study
    Sacca, Francesco
    Lanzillo, Roberta
    Signori, Alessio
    Maniscalco, Giorgia T.
    Signoriello, Elisabetta
    Lo Fermo, Salvatore
    Repice, Annamaria
    Annovazzi, Pietro
    Baroncini, Damiano
    Clerico, Marinella
    Binello, Eleonora
    Cerqua, Raffaella
    Mataluni, Giorgia
    Bonavita, Simona
    Lavorgna, Luigi
    Zarbo, Ignazio Roberto
    Laroni, Alice
    Rossi, Silvia
    Gutierrez, Lorena Pareja
    La Gioia, Sara
    Frigeni, Barbara
    Barcella, Valeria
    Frau, Jessica
    Cocco, Eleonora
    Fenu, Giuseppe
    Clerici, Valentina Torri
    Sartori, Arianna
    Rasia, Sarah
    Cordioli, Cinzia
    Di Sapio, Alessia
    Pontecorvo, Simona
    Grasso, Roberta
    Barrila, Caterina
    Russo, Cinzia Valeria
    Esposito, Sabrina
    Ippolito, Domenico
    Bovis, Francesca
    Gallo, Fabio
    Sormani, Maria Pia
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (09) : 1263 - 1272
  • [38] Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years
    Michael Auer
    Anne Zinganell
    Harald Hegen
    Gabriel Bsteh
    Franziska Di Pauli
    Klaus Berek
    Elena Fava
    Sebastian Wurth
    Thomas Berger
    Florian Deisenhammer
    Scientific Reports, 11
  • [39] Cyclophosphamide in multiple sclerosis: a real-life study on 222 patients
    Beaufils, P. Constant Dit
    Laplaud, D. A.
    Jousset, N.
    Lefrere, F.
    Wiertlewski, S.
    Michel, L.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 897 - 897
  • [40] CLINICAL CORRELATES AND RELEVANCE OF UCLA GIT 2.0 FOR ESOPHAGITIS AND INDICATION FOR ESOPHAGOGASTRODUODENOSCOPY IN REAL-LIFE PATIENTS WITH SYSTEMIC SCLEROSIS
    Zampatti, N.
    Garaiman, A.
    Jordan, S.
    Becker, M. O.
    Maurer, B.
    Dobrota, R.
    Distler, O.
    Mihai, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 714 - 714